Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease

Monitoring of 30 marker candidates in early Parkinson disease as progression markers

(2016) Brit Mollenhauer et al.   NEUROLOGY

Neurodegenerative CSF markers in genetic and sporadic PD: Classification and prediction in a longitudinal study

(2015) Kathrin Brockmann et al.   PARKINSONISM & RELATED DISORDERS

Time- and frequency-domain parameters of heart rate variability and sympathetic skin response in Parkinson’s disease

(2014) Walter Maetzler et al.   JOURNAL OF NEURAL TRANSMISSION

Advanced Glycation End Products and Diabetic Complications

(2014) Varun Parkash Singh et al.   KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study

(2014) C. H. Adler et al.   NEUROLOGY

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

(2013) Judy K. Qiang et al.   ANNALS OF NEUROLOGY

Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort

(2013) B. Mollenhauer et al.   NEUROLOGY

Mitochondrial dysfunction and oxidative stress in Parkinson's disease

(2013) Sudhakar Raja Subramaniam et al.   PROGRESS IN NEUROBIOLOGY

Standard Preanalytical Coding for Biospecimens: Review and Implementation of the Sample PREanalytical Code (SPREC)

(2012) Sabine Lehmann et al.   BIOPRESERVATION AND BIOBANKING

Sensitive CSF ELISAs for the detection of MBL, MASP-2 and functional MBL/MASP-2

(2012) Janet Y. Kwok et al.   JOURNAL OF NEUROSCIENCE METHODS

Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease

(2011) Ivana Devic et al.   BRAIN

The Impact of Delayed Storage on the Measured Proteome and Metabolome of Human Cerebrospinal Fluid

(2011) T. Rosenling et al.   CLINICAL CHEMISTRY

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

(2011) Brit Mollenhauer et al.   LANCET NEUROLOGY

Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers

(2011) Kathrin Brockmann et al.   MOVEMENT DISORDERS

GBA-associated PD presents with nonmotor characteristics

(2011) K. Brockmann et al.   NEUROLOGY

Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies

(2010) Brit Mollenhauer et al.   Biomarkers in Medicine

Reduced but not oxidized cerebrospinal fluid glutathione levels are lowered in Lewy body diseases

(2010) Walter Maetzler et al.   MOVEMENT DISORDERS

Clinical subtypes of Parkinson's disease

(2010) Stephanie M. van Rooden et al.   MOVEMENT DISORDERS

The sour side of neurodegenerative disorders: the effects of protein glycation

(2009) Hugo Vicente Miranda et al.   JOURNAL OF PATHOLOGY

The Effect of Preanalytical Factors on Stability of the Proteome and Selected Metabolites in Cerebrospinal Fluid (CSF)

(2009) Therese Rosenling et al.   JOURNAL OF PROTEOME RESEARCH

Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention

(2009) Malú G. Tansey et al.   NEUROBIOLOGY OF DISEASE

Glial–neuronal interactions underlying fructose utilization in rat hippocampal slices

(2009) Y. Izumi et al.   NEUROSCIENCE

Metabolomic profiling to develop blood biomarkers for Parkinson's disease

(2008) M. Bogdanov et al.   BRAIN

Metabolomic analysis of urine and serum in Parkinson’s disease

(2008) Andrew W. Michell et al.   Metabolomics

Effect of glycosylation on protein folding: A close look at thermodynamic stabilization

(2008) D. Shental-Bechor et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA